HomeSCPI • IDX
add
Organon Pharma Indonesia Tbk PT
Market news
Financials
Income Statement
Revenue
Net income
| (IDR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 640.94B | 26.34% |
Operating expense | 22.14B | -17.88% |
Net income | 6.64B | 108.99% |
Net profit margin | 1.04 | 107.15% |
Earnings per share | — | — |
EBITDA | 9.17B | 111.81% |
Effective tax rate | 5.50% | — |
Balance Sheet
Total assets
Total liabilities
| (IDR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 114.19B | -7.28% |
Total assets | 1.64T | 15.10% |
Total liabilities | 602.97B | 3.80% |
Total equity | 1.03T | — |
Shares outstanding | 3.60M | — |
Price to book | 0.10 | — |
Return on assets | 0.42% | — |
Return on capital | 0.69% | — |
Cash Flow
Net change in cash
| (IDR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 6.64B | 108.99% |
Cash from operations | -21.44B | -125.22% |
Cash from investing | 10.69B | 154.17% |
Cash from financing | 443.68M | 100.30% |
Net change in cash | -11.99B | 85.82% |
Free cash flow | -27.97B | -143.42% |
About
Founded
1972
Website
Employees
182
